Related Experiment Video
Updated: Aug 4, 2026
04:36
Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
Published on: October 2, 2020
Physical measures for treating depression in dialysis patients
K S Rabindranath1, J A Butler, A M Macleod
1Medicine and Therapeutics, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, UK, AB25 2ZD. samuelrabi@rediffmail.com
The Cochrane Database of Systematic Reviews
|April 23, 2005
Summary
This review found insufficient evidence to confirm the effectiveness of physical treatments for depression in dialysis patients due to a lack of large, long-term studies. More research is needed to establish safe and effective interventions for this population.
Area of Science:
- Nephrology
- Psychiatry
- Clinical Trials
Background:
- Depression is highly prevalent in chronic dialysis patients, complicating diagnosis due to overlapping symptoms with uremia.
- Renal impairment and cardiovascular issues in dialysis patients present challenges for pharmacological depression treatment.
Purpose of the Study:
- To systematically review the efficacy and safety of physical measures for treating depression in patients undergoing end-stage renal disease dialysis.
Main Methods:
- Conducted a comprehensive search for Randomized Controlled Trials (RCTs) across multiple databases (MEDLINE, EMBASE, PSYCHINFO, Cochrane Library) up to March 2004.
- Included RCTs comparing drugs to placebo, no treatment, or electroconvulsive therapy and drugs.
- Abstracted data independently, calculating relative risk and weighted mean differences with 95% confidence intervals.
Main Results:
- Identified only one small RCT (12 patients, 8 weeks) comparing fluoxetine to placebo.
- This trial found no significant difference in depression scores or safety between fluoxetine and placebo groups.
Conclusions:
- Limited evidence exists regarding the efficacy of physical treatments for depression in dialysis patients due to the scarcity of high-quality, long-term RCTs.
- Further large-scale, extended-duration RCTs are necessary to draw firm conclusions.
- Development of validated diagnostic tools is needed, as current depression screening tools have poor specificity in medically ill populations.
Related Concept Videos
01:27Dialysis
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:25Peritoneal Dialysis III: Nursing Management
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
01:24Hemodialysis II: Procedure and Complications
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
01:25Hemodialysis III: Nursing Management
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...